The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction.

CONCLUSION: Current evidence supports the central role of aldosterone in HFrEF progression, and the significant benefits on outcomes with the use of MRAs.
PMID: 30806305 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Design - February 19, 2019 Category: Drugs & Pharmacology Authors: Papademetriou V, Toumpourleka M, Imprialos KP, Alataki S, Manafis A, Stavropoulos K Tags: Curr Pharm Des Source Type: research